Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,141,122
  • Shares Outstanding, K 122,970
  • Annual Sales, $ 444,450 K
  • Annual Income, $ 4,170 K
  • 60-Month Beta 0.66
  • Price/Sales 13.87
  • Price/Cash Flow 116.45
  • Price/Book 5.27
Trade NEO with:

Options Overview Details

View History
  • Implied Volatility 52.64%
  • Historical Volatility 44.22%
  • IV Percentile 67%
  • IV Rank 52.91%
  • IV High 66.40% on 10/19/20
  • IV Low 37.17% on 09/16/21
  • Put/Call Vol Ratio 0.13
  • Today's Volume 987
  • Volume Avg (30-Day) 464
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 6,829
  • Open Int (30-Day) 3,965

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.10
  • Number of Estimates 3
  • High Estimate -0.08
  • Low Estimate -0.13
  • Prior Year 0.04
  • Growth Rate Est. (year over year) -350.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.43 +3.15%
on 08/25/21
53.43 -12.30%
on 09/23/21
+1.18 (+2.58%)
since 08/24/21
3-Month
40.49 +15.72%
on 08/11/21
53.43 -12.30%
on 09/23/21
+0.45 (+0.97%)
since 06/24/21
52-Week
34.53 +35.70%
on 09/25/20
61.57 -23.89%
on 02/16/21
+11.81 (+33.69%)
since 09/24/20

Most Recent Stories

More News
NeoGenomics' Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Further Validate the Application of its RaDaR(TM) MRD and InVisionFirst(R)-Lung Assays at the ESMO Congress 2021

FT MYERS, FL / ACCESSWIRE / September 9, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced...

NEO : 46.86 (-6.17%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 184.80 (-1.19%)
OMCL : 154.25 (-1.31%)
AMN : 115.25 (-0.20%)
NEO : 46.86 (-6.17%)
XLV : 131.98 (-0.41%)
VHT : 257.37 (-0.57%)
NeoGenomics (NEO) Reports Q2 Loss, Tops Revenue Estimates

NeoGenomics (NEO) delivered earnings and revenue surprises of 80.00% and 1.02%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

NEO : 46.86 (-6.17%)
NeoGenomics Reports 40% Revenue Growth to $122 Million in the Second Quarter

NEO : 46.86 (-6.17%)
Earnings Preview: NeoGenomics (NEO) Q2 Earnings Expected to Decline

NeoGenomics (NEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NEO : 46.86 (-6.17%)
Bear of the Day: NeoGenomics (NEO)

Emerging diagnostics provider is steadily growing sales and key M&A but ran into an EPS cliff

NEO : 46.86 (-6.17%)
EXAS : 96.02 (-2.24%)
NVTA : 30.06 (-6.62%)
NTRA : 118.12 (-4.39%)
GH : 128.40 (-0.71%)
NeoGenomics Schedules its Second Quarter 2021 Earnings Release for August 6, 2021

FT. MYERS, FL / ACCESSWIRE / July 14, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to...

NEO : 46.86 (-6.17%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 184.80 (-1.19%)
OMCL : 154.25 (-1.31%)
AMN : 115.25 (-0.20%)
NEO : 46.86 (-6.17%)
XLV : 131.98 (-0.41%)
VHT : 257.37 (-0.57%)
NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform

Acquisition establishes NeoGenomics as a technology leader in the minimal residual disease (MRD) testing market

NEO : 46.86 (-6.17%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 184.80 (-1.19%)
OMCL : 154.25 (-1.31%)
NEO : 46.86 (-6.17%)
XLV : 131.98 (-0.41%)
VHT : 257.37 (-0.57%)
ENSG : 75.40 (-0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

3rd Resistance Point 51.90
2nd Resistance Point 50.79
1st Resistance Point 48.83
Last Price 46.86
1st Support Level 45.76
2nd Support Level 44.65
3rd Support Level 42.69

See More

52-Week High 61.57
Fibonacci 61.8% 51.24
Fibonacci 50% 48.05
Last Price 46.86
Fibonacci 38.2% 44.86
52-Week Low 34.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar